Evaluation of liposomal behavior in the gastrointestinal tract after oral administration using real-time in vivo imaging

Reference

• Yu M, Wu J, Shi J, et al. Nanotechnology for protein delivery: overview and perspectives. J Control Release. 2016;240:24–37.
   PubMed Web of Science ®Google Scholar
• Liu Y, Tseng YC, Huang L. Biodistribution studies of nanoparticles using fluorescence imaging: a qualitative or quantitative method? Pharm Res. 2012;29:3273–3277.
   PubMed Web of Science ®Google Scholar
• Takeuchi H, Yamamoto H, Niwa T, et al. Enteral absorption of insulin in rats from mucoadhesive chitosan-coated liposomes. Pharm Res. 1996;13:896–901.
   PubMed Web of Science ®Google Scholar
• Karn PR, Vanic Z, Pepic I, et al. Mucoadhesive liposomal delivery systems: the choice of coating material. Drug Dev Ind Pharm. 2011;37:482–488.
   PubMed Web of Science ®Google Scholar
• Huang A, Su Z, Li S, et al. Oral absorption enhancement of salmon calcitonin by using both N-trimethyl chitosan chloride and oligoarginines-modified liposomes as the carriers. Drug Deliv. 2014;21:388–396.
   PubMed Web of Science ®Google Scholar
• Barea MJ, Jenkins MJ, Gaber MH, et al. Evaluation of liposomes coated with a pH responsive polymer. Int J Pharm. 2010;402:89–94.
   PubMed Web of Science ®Google Scholar
• Thongborisute J, Takeuchi H, Yamamoto H, et al. Visualization of the penetrative and mucoadhesive properties of chitosan and chitosan-coated liposomes through the rat intestine. J Liposome Res. 2006;16:127–141.
   PubMed Web of Science ®Google Scholar
• Tahara K, Fujimoto S, Fujii F, et al. Quantum dot-loaded liposomes to evaluate the behavior of drug carriers after oral administration. J Pharm. 2013;2013:6.
   Google Scholar
• Ponchel G, Montisci M-J, Dembri A, et al. Mucoadhesion of colloidal particulate systems in the gastro-intestinal tract. Eur J Pharm Biopharm. 1997;44:25–31.
   Web of Science ®Google Scholar
• Murata M, Tahara K, Takeuchi H. Real-time in vivo imaging of surface-modified liposomes to evaluate their behavior after pulmonary administration. Eur J Pharm Biopharm. 2014;86:115–119.
   PubMed Web of Science ®Google Scholar
• Lozano N, Al-Ahmady ZS, Beziere NS, et al. Monoclonal antibody-targeted PEGylated liposome-ICG encapsulating doxorubicin as a potential theranostic agent. Int J Pharm. 2015;482:2–10.
   PubMed Web of Science ®Google Scholar
• Beziere N, Lozano N, Nunes A, et al. Dynamic imaging of PEGylated indocyanine green (ICG) liposomes within the tumor microenvironment using multi-spectral optoacoustic tomography (MSOT). Biomaterials. 2015;37:415–424.
   PubMed Web of Science ®Google Scholar
• Proulx ST, Luciani P, Derzsi S, et al. Quantitative imaging of lymphatic function with liposomal indocyanine green. Cancer Res. 2010;70:7053–7062.
   PubMed Web of Science ®Google Scholar
• Kono K, Takashima M, Yuba E, et al. Multifunctional liposomes having target specificity, temperature-triggered release, and near-infrared fluorescence imaging for tumor-specific chemotherapy. J Control Release. 2015;216:69–77.
   PubMed Web of Science ®Google Scholar
• Portnoy E, Vakruk N, Bishara A, et al. Indocyanine green liposomes for diagnosis and therapeutic monitoring of cerebral malaria. Theranostics. 2016;6:167–176.
   PubMed Web of Science ®Google Scholar
• Tang J, Kuai R, Yuan W, et al. Effect of size and pegylation of liposomes and peptide-based synthetic lipoproteins on tumor targeting. Nanomedicine. 2017;13:1869–1878.
   PubMed Web of Science ®Google Scholar
• Zheng C, Zheng M, Gong P, et al. Indocyanine green-loaded biodegradable tumor targeting nanoprobes for in vitro and in vivo imaging. Biomaterials. 2012;33:5603–5609.
   PubMed Web of Science ®Google Scholar
• Goldberg MS, Xing D, Ren Y, et al. Nanoparticle-mediated delivery of siRNA targeting Parp1 extends survival of mice bearing tumors derived from Brca1-deficient ovarian cancer cells. Proc Natl Acad Sci USA. 2011;108:745–750.
   PubMed Web of Science ®Google Scholar
• Yao Y, Su Z, Liang Y, et al. pH-Sensitive carboxymethyl chitosan-modified cationic liposomes for sorafenib and siRNA co-delivery. Int J Nanomedicine. 2015;10:6185–6197.
   PubMed Web of Science ®Google Scholar
• Makhlof A, Werle M, Tozuka Y, et al. Nanoparticles of glycol chitosan and its thiolated derivative significantly improved the pulmonary delivery of calcitonin. Int J Pharm. 2010;397:92–95.
   PubMed Web of Science ®Google Scholar
• Takeuchi H, Yamamoto H, Kawashima Y. Mucoadhesive nanoparticulate systems for peptide drug delivery. Adv Drug Deliv Rev. 2001;47:39–54.
   PubMed Web of Science ®Google Scholar
• Yeh TH, Hsu LW, Tseng MT, et al. Mechanism and consequence of chitosan-mediated reversible epithelial tight junction opening. Biomaterials. 2011;32:6164–6173.
   PubMed Web of Science ®Google Scholar
• Dickinson E, Eriksson L. Particle flocculation by adsorbing polymers. Adv Colloid Interface Sci. 1991;34:1–29.
   Web of Science ®Google Scholar
• Takeuchi H, Thongborisute J, Matsui Y, et al. Novel mucoadhesion tests for polymers and polymer-coated particles to design optimal mucoadhesive drug delivery systems. Adv Drug Del Rev. 2005;57:1583–1594.
   PubMed Web of Science ®Google Scholar
• Han HK, Shin HJ, Ha DH. Improved oral bioavailability of alendronate via the mucoadhesive liposomal delivery system. Eur J Pharm Sci. 2012;46:500–507.
   PubMed Web of Science ®Google Scholar
• Sugihara H, Yamamoto H, Kawashima Y, et al. Effectiveness of submicronized chitosan-coated liposomes in oral absorption of indomethacin. J Liposome Res. 2012;22:72–79.
   PubMed Web of Science ®Google Scholar
• Sugihara H, Yamamoto H, Kawashima Y, et al. Effects of food intake on the mucoadhesive and gastroretentive properties of submicron-sized chitosan-coated liposomes. Chem Pharm Bull. 2012;60:1320–1323.
   PubMed Web of Science ®Google Scholar
• Takeuchi H, Matsui Y, Sugihara H, et al. Effectiveness of submicron-sized, chitosan-coated liposomes in oral administration of peptide drugs. Int J Pharm. 2005;303:160–170.
   PubMed Web of Science ®Google Scholar
• Bjornsson OG, Murphy R, Chadwick VS. Physiochemical studies of indocyanine green (ICG): absorbance/concentration relationship, pH tolerance and assay precision in various solvents. Experientia. 1982;38:1441–1442.
   PubMedGoogle Scholar
• Lai SK, Wang YY, Hanes J. Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues. Adv Drug Deliv Rev. 2009;61:158–171.
   PubMed Web of Science ®Google Scholar